TABLE 3 from Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry

Frequencies of genomic alterations in tumor samples—Results are displayed for genomic alterations present in at least 7% of tumor specimens and tested in at least 20% of the tumor specimens, as well as NRAS and MED12. Frequencies do not reflect OncoKB annotation. Details of specific NGS panels performed can be found in the GENIE data guide (www.aacr.org/wp-content/uploads/2022/02/GENIE_data_guide_11.0-public-1.pdf)